The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.50
Bid: 92.00
Ask: 97.00
Change: -0.50 (-0.53%)
Spread: 5.00 (5.435%)
Open: 95.00
High: 95.00
Low: 94.50
Prev. Close: 95.00
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR shareholding – acquisition of shares

24 Nov 2021 07:00

RNS Number : 3392T
Transense Technologies PLC
24 November 2021
 

24 November 2021

 

Transense Technologies plc

("Transense" or the "Company")

 

Director/PDMR shareholding - acquisition of shares

 

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, has been notified that on 23 November 2021 Ryan Maughan, who will join the board with effect from 1 December 2021, purchased 7,086 ordinary shares in the Company at £1.06p per share. Accordingly, Ryan Maughan's total beneficial shareholding in the Company has increased to 12,251 ordinary shares, which represents 0.075% of the issued share capital.

 

Further details are provided in the forms below in accordance with the requirements of the UK Market Abuse Regulation.

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO) Via Walbrook PR

 

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking) Tel: +44 (0)20 3328 5656

 

Walbrook PR

Tom Cooper/Nick Rome/Nicholas Johnson Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

 

 

 

Notes to Editors:

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include aerospace, automotive (high performance and off-road) and complex machine control.

The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com

For further information please contact transense@walbrookpr.com.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Ryan Maughan

2

 

Reason for the notification

a)

 

Position/status

 

 

Director (designate)

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name 

 

Transense Technologies plc

b)

 

LEI

 

2138005N52J6KKQ3EY67

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10 pence each

 

 

Identification code

GB00BDHDTH21

 

 

b)

 

Nature of the transaction 

 

Purchase of Ordinary Shares

c)

Price and volume

Price: 106 pence per share

 

Volume: 7,086

d)

 

Aggregated information

 

- Aggregated volume

As above

- Price

 

 

 

e)

 

Date of the transaction

 

23 November 2021

f)

 

Place of the transaction

 

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPGUGGUPGPUW
Date   Source Headline
21st Oct 20082:17 pmRNSHolding(s) in Company
20th Oct 200812:52 pmRNSDirector/PDMR Shareholding
17th Oct 20087:30 amRNSResponse to share price movement
13th Oct 200810:04 amRNSHolding(s) in Company
9th Oct 200810:09 amRNSHolding(s) in Company
19th Sep 200812:07 pmRNSHolding(s) in Company
16th Sep 20082:52 pmRNSDirector/PDMR Shareholding
4th Sep 20087:00 amRNSInterim Results
29th Aug 20083:45 pmRNSNotice of Results
26th Aug 20083:58 pmRNSHolding(s) in Company
30th Jul 200812:01 pmRNSHolding(s) in Company
29th Jul 20082:29 pmRNSHolding(s) in Company
15th Jul 20082:00 pmRNSRe Agreement
25th Jun 20087:00 amRNSDirector/PDMR Shareholding
2nd Jun 20087:19 amRNSDirectorate Change
15th Apr 20082:58 pmRNSDirector/PDMR Shareholding
15th Apr 200812:46 pmRNSPreliminary Results
10th Apr 20089:05 amRNSNotice of Results
4th Apr 20083:49 pmRNSHolding(s) in Company
3rd Apr 200812:47 pmRNSDirectorate Change
20th Mar 20084:24 pmRNSHolding(s) in Company
20th Mar 20084:19 pmRNSHolding(s) in Company-Amend
19th Mar 20084:00 pmRNSTotal Voting Rights
18th Mar 20082:49 pmRNSHolding(s) in Company
11th Mar 20085:43 pmRNSDirector Details
25th Feb 20082:41 pmRNSHolding(s) in Company
8th Feb 20087:30 amRNSDirector Declaration
8th Feb 20087:00 amRNSBoard and Adviser Change
16th Jan 20082:47 pmRNSHolding(s) in Company
4th Jan 200812:08 pmRNSResult of General Meeting
13th Dec 200710:08 amRNSGrant of Options
10th Dec 200712:56 pmRNSFurther update
7th Dec 20078:00 amRNSAdditional Listing
3rd Dec 200712:18 pmRNSProposed Directorate Changes
21st Nov 20077:30 amRNSRestoration - Transense Techn
21st Nov 20077:30 amRNSFurther Update
20th Nov 200712:14 pmRNSHolding(s) in Company
16th Nov 20073:51 pmRNSResult of EGM
16th Nov 20073:51 pmRNSSuspension - Transense Tech
16th Nov 200710:47 amRNSHolding(s) in Company
15th Nov 20077:03 amRNSGeneral Meeting update
13th Nov 20073:58 pmRNSSchedule 1 - Transense Techno
13th Nov 20077:00 amRNSGeneral Meeting update
2nd Nov 20075:51 pmRNSSchedule 1 - Transense Techno
2nd Nov 200712:53 pmRNSConference Call
26th Oct 20077:30 amRNSConference call
24th Oct 200711:02 amRNSHolding(s) in Company
22nd Oct 20071:30 pmRNSRestoration - Transense Techn
22nd Oct 20071:30 pmRNSAcquisition
17th Oct 20077:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.